Properties and bioaccessibility of arsenic sulphide nanosuspensions

Materials Letters

Volumn 104, Issue , 2013, Pages 84-86

  Baláž, Peter ^a   Bujňáková, Zdenka ^a   Kartachova, Olga ^b,c   Fabián, Martin ^a   Stalder, Bernhardt ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Buhler AG   (Switzerland)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

Arsenic sulphide; Dissolution; Nanomilling; Nanoparticle

Indexed keywords

DISSOLUTION; MILLING (MACHINING); NANOPARTICLES; PARTICLE SIZE; SULFUR COMPOUNDS;

ARSENIC SULPHIDE; BIOACCESSIBILITY; DISSOLUTION TESTS; INTESTINAL FLUID; MEAN PARTICLE SIZE; MONOMODAL DISTRIBUTION; NANOMILLING; POTENTIAL VALUES;

ARSENIC;

EID: 84880050346     PISSN: 0167577X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matlet.2013.04.003     Document Type: Article

References (21)

1. Wang ZY. Cancer Chemother Pharmacol 2001; 48: 72-6.
2. Zhao W, Lu X, Yuan Y, Liu C, Yang B, Hong H, et al. Int J Nanomed 2011; 6: 1569-77.
3. Ou SJ, Shen XC, Jin T, Xie J, Guo YF, Liang H, et al. Front Mater Sci China 2010; 4: 339-44.
4. Liu J, Lu Y, Wu Q, Goyer RA, Waalkes MP. J Pharmacol Exp Ther 2008; 326: 363-8.
5. Baláž P, Sedlák J. Toxins 2010; 2: 1568-81.
6. Deng Y, Xu HB, Huang KX, Yang XL, Xie CS, Wu J. Pharmacol Res 2001; 44: 513-8.
7. Ye HQ, Yang XL, Gan L, Sun XH, Xu HB Proceedings of the 27th annual conference on engineering medicine and biology, Shanghai, IEEE, 2005. p. 7714-7.
8. Wu JZ, Ho PC. Eur J Pharm Sci 2006; 29: 35-44.
9. Baláž P, Fabián M, Pastorek M, Cholujová D, Sedlák J. Mater Lett 2009; 63: 1542-4.
10. Baláž P, Nguyen AV, Fabián M, Cholujová D, Pastorek M, Sedlák J, et al. Powder Technol 2011; 211: 232-6.
11. Baláž P, Sedlák J, Pastorek M, Cholujová D, Vignarooban K, Bhosle S, et al. J Nano Res 2012; 18-19: 149-55.
12. An YL, Nie F, Wang ZY, Zhang DS. Int J Nanomed 2011; 6: 3187-94.
13. Chen P, Yan L, Wang Q, Li Y, Li H. Int Microbiol 2012; 15: 9-15.
14. Gao L, Liu GY, Ma JL, Wang XQ, Zhou L, Li X. J Control Release 2012; 160: 418-30.
15. Hörter D, Dressman JB. Adv Drug Deliver Rev 2011; 46: 75-87.
16. Kesisoglou F, Panmai S, Wu Y. Adv Drug Deliver Rev 2007; 59: 631-44.
17. Petronen L, Hirvonen J. J Pharm Pharmacol 2010; 60: 1569-79.
18. Merisko-Liversidge E, Liversidge GG. Adv Drug Deliver Rev 2011; 63: 427-40.
19. Shen XC, Jin T, Xie J, Liang H, Yan Y. Sci China Ser B 2009; 59: 1512-8.
20. Kwan SY, Tsui SK, Man TO. Anal Lett 2001; 34: 1431-6.
21. Koch J, Sylvester S, Lai VWM, Owen A, Reimer KJ, Cullen WR. Toxicol Appl Pharm 2007; 222: 357-64.